These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 812218)

  • 21. A simple rosette assay for demonstration of complement receptor sites using complement-coated zymosan beads.
    Huber Ch; Wigzell H
    Eur J Immunol; 1976 Jun; 5(6):432-5. PubMed ID: 1086242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An enzyme-linked immunosorbent assay for the detection of complement components on red blood cells.
    Sirois M; Chartier C; Brun G; Hamel Y; Petitclerc C; Delage JM
    Am J Clin Pathol; 1984 Jul; 82(1):67-73. PubMed ID: 6377872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation and fragmentation of the third (C3) and the fourth (C4) components of complement: generation and isolation of physiologically relevant fragments C3c and C4c.
    Janatova J; Gobel RJ
    J Immunol Methods; 1985 Dec; 85(1):17-26. PubMed ID: 4078308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of complement components on cells and in cell interactions.
    Hobart MJ
    Exp Cell Biol; 1976; 44(3-6):226-34. PubMed ID: 1029664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The significance of complement in immunohematology.
    Garratty G
    Crit Rev Clin Lab Sci; 1984; 20(1):25-56. PubMed ID: 6373144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.
    Atkinson JP; Frank MM
    J Clin Invest; 1974 Aug; 54(2):339-48. PubMed ID: 4847248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemolysis of normal human erythrocytes by autologous serum complement.
    Kitamura H; Nagano A; Kitano E
    Int Arch Allergy Immunol; 1993; 100(3):209-14. PubMed ID: 8453307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The rapid identification of Chido and Rodgers antibodies using C4d-coated red blood cells.
    Judd WJ; Kraemer K; Moulds JJ
    Transfusion; 1981; 21(2):189-92. PubMed ID: 7222201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. I. Functional differences among C4 sites on cell surfaces.
    Borsos T; Rapp HJ; Colten HR
    J Immunol; 1970 Dec; 105(6):1439-46. PubMed ID: 4991793
    [No Abstract]   [Full Text] [Related]  

  • 31. Alternative complement pathway activation by C4b deposited during classical pathway activation.
    Matsushita M; Okada H
    J Immunol; 1986 Apr; 136(8):2994-8. PubMed ID: 2937839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemolytic activity of leukemic sera: the role of complement and sucrose.
    Berchtold PE; Spaeth PJ; Haeberli A; Straub PW
    J Lab Clin Med; 1986 Jun; 107(6):544-50. PubMed ID: 3086472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chido, Rodgers and C4. In vivo and in vitro coating of red blood cells, grouping and antibody detection.
    Nordhagen R; Heier Larsen AM; Beckers D
    Vox Sang; 1979; 37(3):170-8. PubMed ID: 91269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemolytic transfusion reactions caused by failure of commercial antiglobulin reagents to detect complement.
    Sherwood GK; Haynes BF; Rosse WF
    Transfusion; 1976; 16(5):417-20. PubMed ID: 1068582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter: Isolation of C3b receptors from human erythrocytes.
    Okuda T; Tachibana T
    Jpn J Exp Med; 1976 Jun; 46(3):201-3. PubMed ID: 957525
    [No Abstract]   [Full Text] [Related]  

  • 36. The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytes.
    Goers JW; Porter RR
    Biochem J; 1978 Nov; 175(2):675-84. PubMed ID: 743217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum-red cell interactions at low ionic strength: erythrocyte complement coating and hemolysis of paroxysmal nocturnal hemoglobinuria cells.
    Jenkins DE; Hartmann RC; Kerns AL
    J Clin Invest; 1967 May; 46(5):753-61. PubMed ID: 6025481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemolytic anemia associated with multiple autoantibodies and low serum complement.
    Moake JL; Schultz DR
    Am J Med; 1975 Mar; 58(3):431-7. PubMed ID: 1078754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Features of serum complement C3 and C4 levels in autoimmune hemolytic anemia patients.
    Wang Z; Bo L; Xu Y; Liu H; Zhao Y
    Int J Lab Hematol; 2021 Oct; 43(5):1154-1158. PubMed ID: 33459487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlations between quantitative assay of red cell-bound C3, serologic reactions, and hemolytic anemia.
    Fischer JT; Petz LD; Garratty G; Cooper NR
    Blood; 1974 Sep; 44(3):359-73. PubMed ID: 4211894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.